MYOCARDIAL ISCHEMIA-REPERFUSION (I/R) injury occurs during cardiac surgery and leads to production of inflammatory cytokines, as well as cardiomyocyte apoptosis and necrosis, all of which exacerbate postischemic myocardial dysfunction. Although there have been many studies focused on minimizing the adverse effects of I/R injury, few have resulted in significant clinical benefits. Sex differences have been noted in the myocardial response to ischemic injury with females exhibiting improved cardiac function, diminished inflammatory response, and reduced apoptotic signaling (17, 19) . Studies from our group (25) and others (10) have further demonstrated that estrogen mediates cardioprotection in females following acute I/R. However, this notion was recently challenged by controversial results from clinical trials that did not demonstrate a cardioprotective effect of hormone replacement therapy on postmenopausal females (16) . This led to a recognition that estrogen-mediated cardioprotection appears more complicated than originally thought and requires more research.
The effects of estrogen are mediated mostly through estrogen receptor ␣ (ER␣) and/or estrogen receptor ␤ (ER␤), both of which are expressed in the heart and have been involved in regulating cardioprotection (9, 22) . In fact, deficiency of the ER␤ gene worsens cardiac dysfunction following myocardial ischemic injury (2, 6, 13) . In addition, a selective ER␤ agonist, 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), protects the myocardium from acute ischemia in ovariectomized (OVX) females (11) . Furthermore, 17␤-estradiol (E2) has been shown to suppress cardiomyocyte apoptosis via activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway during myocardial infarction (12, 15) . However, it is unknown whether this action is mediated through ER␤. On the other hand, our group has previously demonstrated TNF receptor 1 (TNFR1) signaling resistance as well as upregulated signal transduction and activator of transcription 3 (STAT3)/ suppressor of cytokine signaling 3 (SOCS3)/VEGF cascade in female hearts following I/R (23, 24) . It is important to elucidate whether ER␤ plays a role in these pathways. Therefore, with the use of mice containing a targeted deletion of ER␤, this study aimed to determine 1) whether ER␤ mediates protection of cardiac function through PI3K/Akt and antiapoptotic signaling in females, but not males, following acute I/R injury and 2) whether ER␤ may facilitate this cardioprotection via TNFR/STAT3/SOCS3/VEGF-mediated cascades.
MATERIALS AND METHODS

Animals.
A total of 20 male and female C57BL/6J mice (16 Ϯ 4 wk) with and without ER␤ deficiency (ER␤KO; Taconic Farms, Hudson, NY) were fed a standard diet and acclimated in a quiet quarantine room for more than 1 mo before the experiments. The animal protocol was reviewed and approved by the Indiana Animal Care and Use Committee of Indiana University. All animals received humane care in compliance with the "Guide for the Care All isolated mouse hearts were subjected to the same I/R protocol as described previously (23, 24) . Mouse hearts were divided into four experimental groups: normal males (n ϭ 5), ER␤KO males (n ϭ 5), normal females (n ϭ 5), and ER␤KO females (n ϭ 5).
Isolated heart preparation (Langendorff). Experiments were performed with the use of a Langendorff apparatus as described previously for mouse hearts (24 International, Saco, ME). Membranes were then incubated with horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG secondary antibody (Pierce, Rockford, IL), and detection was performed using SuperSignal West Pico stable peroxide solution (Pierce). Films were scanned using an Epson Perfection 3200 scanner (Epson America, Long Beach, CA), and band density was analyzed using ImageJ software (NIH, Bethesda, MD).
Enzyme-linked immunosorbent assay. Myocardial VEGF levels in the cardiac tissue were determined by enzyme-linked immunosorbent assay (ELISA) using a commercially available ELISA set (Duo Set ELISA development system; R&D Systems, Minneapolis, MN). ELISA was performed according to the manufacturer's instructions. All samples and standards were measured in duplicate.
Presentation of data and statistical analysis. All reported values are means Ϯ SE. Data were compared using one-way ANOVA with post hoc Tukey's test or Student's t-test (male WT vs. female WT, male WT vs. male ER␤KO, and female WT vs. female ER␤KO). A two-tailed P value of Ͻ0.05 was considered statistically significant.
RESULTS
Myocardial function. LVDP at the end of reperfusion was exhibited as a percentage of equilibration. I/R injury decreased myocardial LVDP in both WT and ER␤KO mice (Fig. 1) . Deficiency of the ER␤ gene did not significantly affect myocardial recovery of LVDP in male hearts following I/R (35.9 Ϯ 8 vs. WT 45.2 Ϯ 4.7%), whereas ER␤KO markedly decreased LVDP recovery in female hearts (43 Ϯ 6.3%) compared with female WT (62.9 Ϯ 2.9%, P Ͻ 0.05). In addition, sex difference existed in I/R-depressed myocardial function with improved LVDP in female WT hearts compared with male WT. However, ablation of the ER␤ gene neutralized this difference following I/R.
Effects of ER␤ on myocardial PI3K/Akt signaling during acute I/R. Myocardial ischemia increases activation of the PI3K/Akt pathway, which in turn mediates cardiomyocyte survival in response to I/R injury. Ablation of the ER␤ gene significantly decreased myocardial PI3K/Akt activation in females after I/R. ER␤KO reduced activation of PI3K from 47.6% (percentage of p-PI3K/total PI3K) in WT to 14.6% ( Fig. 2A) and Akt from 190% (percentage of p-Akt/total Akt) to 91.3% in female hearts (Fig. 2B) . Although deficiency of ER␤ decreased PI3K activation, the KO did not affect myocardial Akt activation in males (Fig. 2) .
Effects of ER␤ on myocardial apoptotic proteins after I/R injury. Given that the experimental period in this study is too brief (20-min ischemia followed by 60-min reperfusion) to detect significant apoptosis, we measured proapoptotic signaling by examining caspase-3 and -8 and antiapoptotic protein Bcl-2 expression instead. ER␤KO significantly increased myocardial expression of caspase-3 and -8 and reduced Bcl-2 in females following I/R (Fig. 3) . This suggests that ER␤ may mediate antiapoptotic signaling and improve cardiomyocyte survival in female hearts. However, ablation of ER␤ appeared to have an opposite effect in males, since a trend of decreased caspase-3 and -8 and enhanced Bcl-2 levels were noted in male ER␤KO hearts (Fig. 3) . It is possible that sex differences exists in ER␤-mediated apoptotic signaling following acute I/R.
Effects of ER␤ on myocardial TNFR/STAT3/SOCS3/VEGF cascade after I/R injury.
Although a trend of decreased STAT3 activation was observed in female ER␤KO hearts, deficiency of ER␤ did not significantly change myocardial STAT3 activation, TNFR1 and TNFR2 expression, SOCS3 levels, or VEGF production in either sex after acute I/R (Fig. 4) .
Effects of ER␤ on myocardial activation of MAPKs after I/R injury. MAPK pathways (p38 MAPK, JNK, and ERK1/2) play important roles in myocardial inflammation, cardiac function, and cardiomyocyte death following I/R. In males, ablation of ER␤ did not affect myocardial activation of p38 MAPK and JNK, whereas increased ERK1/2 activation was noted in the KO hearts (Fig. 5) . Interestingly, enhanced JNK activation was observed in female ER␤KO myocardium in response to I/R, whereas activation of p38 MAPK and ERK1/2 was not changed by deficiency of ER␤ in females (Fig. 5) . This finding suggests that specific sex differences exist in ER␤-mediated MAPK signaling.
DISCUSSION
Accumulating evidence has demonstrated that ER␤ is involved in mediating E2-induced cardioprotection in females following I/R combined with isoproterenol-induced hypercon- tractile condition (2, 11) . In the present study, by utilizing mice lacking ER␤, we found that ER␤ mediates acute myocardial functional protection likely through activation of PI3K/Akt pathway and decreased apoptotic signaling following I/R in females (presumably having a higher baseline levels of endogenous estrogen compared with males) but not in males (Fig. 6) .
ER␤ is a member of the nuclear receptor gene family of transcription factors and may play an important role in protecting against myocardial dysfunction caused by I/R injury. Previously, we indicated that E2, a nonselective ER ligand, improved functional recovery, reduced myocardial inflammation, and diminished proapoptotic signaling following acute ischemia in males as well as OVX females (25) . Recently, deficiency of ER␤ was shown to worsen postischemic myocardial dysfunction in female hearts with hypercontractile condition (2). In addition, DPN, a selective ER␤ agonist, restored E2-mediated cardiac protection in OVX females under conditions of enhanced contractility following I/R injury (11) . In our study, significantly decreased recovery of LVDP was noted in female ER␤KO hearts compared with female WT after acute I/R, whereas ablation of ER␤ did not affect postischemic myocardial functional recovery in males. This result further confirms that ER␤ mediates protection of myocardial function not only in female hearts associated with isoproterenol-enhanced contractility (2, 11) but also in normal females during acute I/R.
ER␤ has been shown to mediate E2-induced cardioprotection through genomic mechanisms including regulation of metabolic gene expression (2, 11) and modulation of ion channel expression and calcium-handling protein (6, 13) . However, it is also possible that ER␤ may be located in the plasma membrane and mediates nongenomic events trigged by E2 (18) . Akt and its upstream signal, PI3K, play critical roles in mediating cell survival and apoptosis (12) . It is evident that the E2-activated PI3K/Akt pathway functions as one of the acute nongenomic actions of E2 in various types of cells (18) . Upregulation of PI3K/Akt by administration of E2 results in endothelial nitric oxide synthase activation via a transcriptionindependent mechanism (3). In addition, activation of the PI3K/Akt pathway is required for E2-suppressed apoptosis and E2-protected myocardial function in the heart following ischemia (12) . Although most studies on the interaction of estrogen receptor with the PI3K/Akt pathway have indicated a crucial role for ER␣ as a membrane-associated receptor engaged in this action (18) , little information exists regarding the importance of ER␤ in the E2-mediated nongenomic effect of PI3K/ Akt activation. In this study, we found significantly reduced activation of the PI3K/Akt pathway in female ER␤KO hearts, but not in males, following acute I/R. This provides evidence that ER␤ is also involved in PI3K/Akt-regulated cardioprotection in females. In fact, ER␤ has been shown to mediate E2-induced antiapoptotic effects through the PI3K/Akt pathway in skeletal muscle cells (21) . In addition, administration of E2 protects cardiac H9c2 cells from oxidative stressinduced apoptosis through ER␤-activated Akt signaling (20) . Consistent with these observations, we have demonstrated that deficiency of the ER␤ gene significantly increases levels of proapoptotic proteins caspase-3 and -8 while reducing antiapoptotic protein Bcl-2 levels in female hearts in response to acute I/R. E2-regulated Akt activation also may mediate myocardial protection via additional mechanisms. Previous studies have demonstrated, for example, that OVX-reduced Akt activation occurs with decreased myocyte contractile function and impaired intracellular calcium handling, whereas E2-upregulated Akt is associated with restored cardiac contractility and intracellular calcium homeostasis (15) . This suggests that Akt signaling may play a role in E2-mediated protection of myocardial function in addition to reduction of apoptosis. Indeed, activation of the Akt pathway also has been linked to a lower incidence of arrhythmias after myocardial infarction (14) . In addition, delivery of a constitutively active Akt mutant gene markedly improves myocardial function in vivo following acute I/R and protects hypoxia-induced cardiomyocyte dysfunction in vitro, likely by preventing hypoxia-induced abnormalities in calcium transients and shortening (7) . Therefore, it is possible that decreased activation of Akt may lead to reduced myocardial recovery of LVDP in female ER␤KO hearts following acute I/R in our study. TNFR1 signaling has been shown to mediate detrimental effects of TNF on the myocardium (8, 24) , whereas the TNFR2 pathway conducts protective effects (4, 23) . Evidence suggests that the balance of TNFR1 and TNFR2 signaling shifts in favor of TNFR2 and its beneficial effects in female hearts during I/R (23, 24) . However, it is unclear whether ER␤ is engaged in the regulatory balance of the TNFR1 and TNFR2 pathways. In addition, TNFR2-induced cardioprotection appears to be mediated through STAT3, SOCS3, and VEGF in female hearts. STAT3 has been shown to be a direct target gene for estradiol (1) ; administration of E2 upregulates STAT3 activation, which partially mediates nongenomic effects of E2 (1) . Therefore, the question arises whether ER␤ is involved in regulating myocardial STAT3/SOCS3/VEGF cascades in females. In this study, we found that ablation of ER␤ did not affect myocardial expression of TNFR1 or TNFR2. In addition, ER␤KO did not change myocardial STAT3/SOCS3/VEGF signaling following I/R. However, further investigation is required to determine whether the myocardial TNFR/STAT3/SOCS3/VEGF cascade is related to E2-mediated cardiac protection and, if so, whether ER␣ plays a role in this action.
MAPKs (p38 MAPK, JNK, and ERK1/2) have been shown to mediate myocardial responses during injury. Activity of p38 MAPK and JNK is related to myocardial dysfunction (5), whereas ERK1/2 activation improves cardiac functional recovery following I/R (22) . In addition, E2 has been reported to block hypoxia-induced activation of p38 MAPK and JNK, thus protecting the myocardium (5, 25) . Conversely, E2-increased activation of ERK1/2 has been shown to inhibit cardiomyocyte apoptosis during myocardial ischemia (22) . It is evident that both ER␣ and ER␤ are involved in regulating myocardial MAPKs (5, 22) . In fact, ER␣ has been shown to upregulate activation of the protective ERK1/2, decrease the proapoptotic JNK activation, and improve myocardial function in females during acute ischemia (22) . In the present study, we further found significantly increased JNK activation in female ER␤KO hearts but elevated ERK1/2 activation in male ER␤KO following I/R. This suggests that sex differences exist in ER␤-mediated MAPK signaling in the hearts in response to acute ischemic injury.
Perspectives and Significance
This study provides the direct evidence of ER␤-mediated cardioprotection in female hearts following acute I/R. Improved myocardial function is associated with ER␤-activated PI3K/Akt pathway and subsequently decreased apoptotic signaling in female hearts in response to I/R. Further investigation is required to elucidate the detailed mechanisms on the specific function of ER subtypes in the heart. Understanding effects of estrogen and estrogen receptors may help in advancing therapeutic manipulations in menopausal females and, potentially, males.
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